Alzheimer’s disease has long shown a troubling gender divide: nearly two-thirds of Americans living with the condition are women. Now, new research offers a fresh lead on why that might be. A large study published in Alzheimer’s & Dementia: The ...

COVID-19 may carry longer-term consequences for the respiratory system beyond the initial infection, according to new research published in the Journal of Allergy and Clinical Immunology. The study, drawing on health records from nearly 5.4 million people, found that those ...

Outbreak Traced to Cooling Towers in Central Harlem New York City health officials have confirmed that a Legionnaires’ disease outbreak in Central Harlem has led to four deaths and sickened at least 101 people. The bacteria responsible for the illness, ...

A New Way to Rally the Immune System For decades, researchers have searched for ways to harness the immune system against cancer without overwhelming the body with dangerous side effects. Now, scientists at Rockefeller University may have inched closer. In ...

For decades, lithium has been known primarily as a mood stabilizer, prescribed in controlled doses to treat bipolar disorder, mania, and severe depression. But science is now uncovering another side to this mineral — one that could reshape how we ...

A New Way to Rally the Immune System Parkinson’s disease disrupts the central nervous system, undermining both motor control and cognitive functions. Affecting more than 10 million people worldwide, it slowly dismantles the brain’s intricate communication pathways, leaving researchers and ...

Golden, crispy, and irresistible—french fries have long held a place on dinner plates and in drive-thru bags. But a new study suggests they may also come with a hidden cost: a higher risk of Type 2 diabetes. Published in The ...

For decades, we’ve been told that getting a good night’s sleep is essential for health. But new findings suggest that what truly matters may not be how long we sleep, but how consistently we do it—and at what times. In ...

With Alzheimer’s disease affecting over 30 million people globally, researchers are racing against time to discover therapies that not only manage symptoms but alter the course of the disease. Now, a team of scientists has found that two existing cancer ...

New Study Suggests GLP-1 Medications Could Improve Asthma in People with Obesity GLP-1 receptor agonists, medications originally designed for managing type 2 diabetes and obesity, are showing unexpected promise in improving asthma control among people with obesity, according to new ...